Patient Care Online articleshttps://www.patientcareonline.com/newsPatient Care Online articles© 2026 MJH Life Sciences™ and Patient Care Online. All rights reserved.Wed, 07 Oct 2026 17:37:08 +00005en-us14447https://www.patientcareonline.com/newshttps://www.patientcareonline.com/logo.webphttps://www.patientcareonline.com/view/fda-clears-ide-for-neuwire-medical-s-stroke-rewire-trial-in-chronic-ischemic-strhttps://www.patientcareonline.com/view/fda-clears-ide-for-neuwire-medical-s-stroke-rewire-trial-in-chronic-ischemic-str<![CDATA[FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.]]>Wed, 07 Oct 2026 17:20:52 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/hiv-testing-before-and-during-prep-getting-it-righthttps://www.patientcareonline.com/view/hiv-testing-before-and-during-prep-getting-it-right<![CDATA[Confirming HIV-negative status before starting PrEP, and at every follow-up, protects against partial treatment and drug resistance. The faculty compare testing strategies across clinical and pharmacy settings.]]>Wed, 07 Oct 2026 12:05:00 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/starting-the-hiv-prep-conversation-in-primary-care-and-pharmacyhttps://www.patientcareonline.com/view/starting-the-hiv-prep-conversation-in-primary-care-and-pharmacy<![CDATA[Patients rarely ask about PrEP unless someone asks first. The faculty describe how primary care clinicians and community pharmacists can open the conversation with confidence and without judgment.]]>Wed, 07 Oct 2026 12:00:00 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/immunizing-against-pain-and-fear-rethinking-the-vaccination-experiencehttps://www.patientcareonline.com/view/immunizing-against-pain-and-fear-rethinking-the-vaccination-experience<![CDATA[Anna Taddio, PhD, explains why the 2026 guideline on vaccine distress treats vaccine pain and fear as a safety issue and what primary care clinicians should know.]]>Tue, 06 Oct 2026 21:12:43 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/9-drugs-approved-for-primary-care-q3-2026https://www.patientcareonline.com/view/9-drugs-approved-for-primary-care-q3-2026<![CDATA[Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.]]>Tue, 06 Oct 2026 20:02:02 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/switch-to-oral-semaglutide-linked-to-4-1-weight-loss-at-3-months-in-new-studyhttps://www.patientcareonline.com/view/switch-to-oral-semaglutide-linked-to-4-1-weight-loss-at-3-months-in-new-study<![CDATA[EASD 2026: Oral semaglutide users lost 4.1% of body weight 3 months after switching from injections in an observational study without a comparator group.]]>Mon, 05 Oct 2026 15:42:31 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/fezolinetant-linked-to-2-6-fewer-nighttime-awakenings-in-women-with-menopausal-vmshttps://www.patientcareonline.com/view/fezolinetant-linked-to-2-6-fewer-nighttime-awakenings-in-women-with-menopausal-vms<![CDATA[Real-world phase 4 data show fezolinetant eases menopausal hot flashes and improves sleep, cutting nighttime awakenings by 2.6 by week 12.]]>Fri, 02 Oct 2026 15:46:17 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/long-term-and-real-world-safety-data-on-antipsychotic-agitation-therapyhttps://www.patientcareonline.com/view/long-term-and-real-world-safety-data-on-antipsychotic-agitation-therapy<![CDATA[Longer follow-up and real-world claims data add context that pivotal trials alone cannot provide. The panel examines both, alongside how monitoring for response actually happens in daily practice.]]>Fri, 02 Oct 2026 12:05:00 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/mechanism-and-trial-data-for-an-antipsychotic-agitation-therapyhttps://www.patientcareonline.com/view/mechanism-and-trial-data-for-an-antipsychotic-agitation-therapy<![CDATA[A second on-label option carries its own distinct mechanism and its own trial history. The panel details how this antipsychotic therapy was studied and what its data actually show.]]>Fri, 02 Oct 2026 12:00:00 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/atrial-fibrillation-stroke-prevention-expert-guidance-for-primary-care-physicianshttps://www.patientcareonline.com/view/atrial-fibrillation-stroke-prevention-expert-guidance-for-primary-care-physicians<![CDATA[Bleeding fears, skipped doses, and cost leave many patients with atrial fibrillation unprotected from stroke. A cardiologist and vascular medicine specialist explains.]]>Thu, 01 Oct 2026 18:36:41 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/5-fda-decisions-for-primary-care-to-know-from-september-2026https://www.patientcareonline.com/view/5-fda-decisions-for-primary-care-to-know-from-september-2026<![CDATA[September FDA news included updates in CKD and type 1 diabetes, major depressive disorder, insulin pump technology, alopecia areata, and more. ]]>Thu, 01 Oct 2026 17:04:05 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/lebrikizumab-improves-hand-and-foot-atopic-dermatitis-in-phase-3b-trialhttps://www.patientcareonline.com/view/lebrikizumab-improves-hand-and-foot-atopic-dermatitis-in-phase-3b-trial<![CDATA[EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.]]>Wed, 30 Sep 2026 18:29:04 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/cagrisema-alters-food-cue-responses-reduces-organ-fat-in-new-analyseshttps://www.patientcareonline.com/view/cagrisema-alters-food-cue-responses-reduces-organ-fat-in-new-analyses<![CDATA[EASD 2026: The combination of semaglutide/cagrilintide altered food-cue responses and showed a 22.4% estimated weight difference vs placebo; separate data found less organ fat in type 2 diabetes.]]>Wed, 30 Sep 2026 16:13:44 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/what-is-hiv-prep-and-who-needs-it-most-https://www.patientcareonline.com/view/what-is-hiv-prep-and-who-needs-it-most-<![CDATA[See how PrEP blocks HIV, who benefits most, and why access gaps hit women, youth, and the South—plus ways to close them.]]>Wed, 30 Sep 2026 13:26:00 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/beyond-semaglutide-and-tirzepatide-the-next-wave-of-obesity-medicineshttps://www.patientcareonline.com/view/beyond-semaglutide-and-tirzepatide-the-next-wave-of-obesity-medicines<![CDATA[Explore how retatrutide, amylin therapies, and oral agents could expand obesity treatment beyond semaglutide and tirzepatide.]]>Tue, 29 Sep 2026 20:10:42 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/fda-grants-priority-review-to-elinzanetant-for-vms-in-hr-breast-cancer-patients-https://www.patientcareonline.com/view/fda-grants-priority-review-to-elinzanetant-for-vms-in-hr-breast-cancer-patients-<![CDATA[The FDA accepted Bayer's sNDA and granted Priority Review to elinzanetant for vasomotor symptoms in women on endocrine therapy for HR+ breast cancer.]]>Tue, 29 Sep 2026 18:31:47 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/detecting-atrial-fibrillation-in-primary-care-warning-signs-and-modifiable-risk-factorshttps://www.patientcareonline.com/view/detecting-atrial-fibrillation-in-primary-care-warning-signs-and-modifiable-risk-factors<![CDATA[Geoffrey Barnes, MD, on why a careful exam is the first line of detection and which 2 risk factors primary care clinicians can actually change.]]>Mon, 28 Sep 2026 20:26:13 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/fda-expands-baricitinib-approval-to-adolescents-with-severe-alopecia-areatahttps://www.patientcareonline.com/view/fda-expands-baricitinib-approval-to-adolescents-with-severe-alopecia-areata<![CDATA[The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.]]>Mon, 28 Sep 2026 14:34:03 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/stroke-incidence-nearly-doubled-among-adults-younger-than-55-over-3-decadeshttps://www.patientcareonline.com/view/stroke-incidence-nearly-doubled-among-adults-younger-than-55-over-3-decades<![CDATA[Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research. ]]>Fri, 25 Sep 2026 20:57:26 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/safety-dosing-and-drug-interactions-for-dextromethorphan-bupropion-in-agitationhttps://www.patientcareonline.com/view/safety-dosing-and-drug-interactions-for-dextromethorphan-bupropion-in-agitation<![CDATA[Safety data, not just efficacy, determines how comfortable clinicians feel prescribing. The panel reviews the safety profile, dosing schedule, and drug interactions relevant to a newer agitation therapy.]]>Fri, 25 Sep 2026 12:05:00 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/pivotal-trials-efficacy-and-safety-of-dextromethorphan-bupropion-in-agitationhttps://www.patientcareonline.com/view/pivotal-trials-efficacy-and-safety-of-dextromethorphan-bupropion-in-agitation<![CDATA[Pivotal trial data can reshape when clinicians feel comfortable starting treatment. The panel walks through the short- and long-term study results behind a newer agitation therapy in detail.]]>Fri, 25 Sep 2026 12:00:00 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/glp-1-ras-for-weight-management-a-primary-care-approach-to-risk-and-monitoringhttps://www.patientcareonline.com/view/glp-1-ras-for-weight-management-a-primary-care-approach-to-risk-and-monitoring<![CDATA[Daniel Drucker, MD, discusses gastrointestinal effects, hydration, pregnancy planning, and unanswered long-term safety questions. ]]>Thu, 24 Sep 2026 22:09:14 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/fda-approves-insulin-efsitora-alfa-gobe-first-once-weekly-basal-insulin-for-typehttps://www.patientcareonline.com/view/fda-approves-insulin-efsitora-alfa-gobe-first-once-weekly-basal-insulin-for-type<![CDATA[The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes. ]]>Thu, 24 Sep 2026 14:56:13 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/individualizing-obesity-treatment-in-primary-care-an-expert-discussionhttps://www.patientcareonline.com/view/individualizing-obesity-treatment-in-primary-care-an-expert-discussion<![CDATA[An endocrinologist discusses the importance of history, comorbidities, lifestyle care, and outcomes beyond weight loss when choosing obesity treatment.]]>Wed, 23 Sep 2026 20:12:02 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/type-2-diabetes-genetic-risk-linked-to-masld-cirrhosis-before-age-50https://www.patientcareonline.com/view/type-2-diabetes-genetic-risk-linked-to-masld-cirrhosis-before-age-50<![CDATA[New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.]]>Wed, 23 Sep 2026 18:13:31 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/fda-approves-sotatercept-csrk-label-update-for-newly-diagnosed-pahhttps://www.patientcareonline.com/view/fda-approves-sotatercept-csrk-label-update-for-newly-diagnosed-pah<![CDATA[FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.]]>Tue, 22 Sep 2026 14:46:21 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/lyme-seropositivity-linked-to-tick-borne-co-exposure-in-us-laboratory-studyhttps://www.patientcareonline.com/view/lyme-seropositivity-linked-to-tick-borne-co-exposure-in-us-laboratory-study<![CDATA[A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.]]>Mon, 21 Sep 2026 20:47:50 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/lumateperone-reduces-acute-mania-symptoms-in-phase-3-bipolar-i-trialhttps://www.patientcareonline.com/view/lumateperone-reduces-acute-mania-symptoms-in-phase-3-bipolar-i-trial<![CDATA[Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson &amp; Johnson. ]]>Mon, 21 Sep 2026 15:34:36 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/cuffless-blood-pressure-devices-fall-short-of-clinical-standardshttps://www.patientcareonline.com/view/cuffless-blood-pressure-devices-fall-short-of-clinical-standards<![CDATA[Pamela Kushner, MD, explains why smartwatches and other cuffless monitors remain unvalidated for hypertension diagnosis and management.]]>Mon, 21 Sep 2026 12:05:00 GMTPatient Care OnlineusPatient Care Online Articleshttps://www.patientcareonline.com/view/clinical-inertia-and-poor-measurement-technique-undermine-bp-controlhttps://www.patientcareonline.com/view/clinical-inertia-and-poor-measurement-technique-undermine-bp-control<![CDATA[Pamela Kushner, MD, outlines why clinical inertia and improper blood pressure measurement fuel the nation's control gap.]]>Mon, 21 Sep 2026 12:00:00 GMTPatient Care OnlineusPatient Care Online Articles